Results 41 to 50 of about 347,804 (118)

A scenario‐drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology

open access: yesMolecular Oncology
Circulating tumor DNA (ctDNA) detection has multiple promising applications in oncology, but the road toward implementation in clinical practice is unclear.
Astrid Kramer   +10 more
doaj   +1 more source

Case report: Clinical and genetic features of pediatric choroidal melanoma

open access: yesFrontiers in Medicine
Uveal melanoma (UM) is the second most common type of primary melanoma in adults, but it is extremely rare in children. We report a 12-year-old boy with a rare juvenile case of UM characterized by specific clinical and genetic features, including eye ...
Paola Valente   +12 more
doaj   +1 more source

Retraction: Frequencies of Porphyromonas gingivalis detection in oral-digestive tract tumors

open access: yesPathology and Oncology Research, 2023
Pathology and Oncology Research Editorial Office
doaj   +1 more source

High Dose Progesterone Loaded PCL‐Polysorbate 80 Transdermal Fibers for Potential Application in Gynecological Oncology

open access: yesMacromolecular Materials and Engineering
Progesterone (P4), commonly administered in high doses for endometrial cancer palliative management, has limitations in current delivery systems. This preliminary in vitro drug release study introduces electrospun patches to offer a new perspective on P4
Omar Shafi   +4 more
doaj   +1 more source

External validation of a novel cancer-associated venous thromboembolism risk assessment score in a safety-net hospital

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: Cancer-associated thrombosis (CAT) is a leading cause of death in patients diagnosed with cancer. However, pharmacologic thromboprophylaxis use in cancer patients must be carefully evaluated due to a 2-fold increased risk of experiencing a ...
Karlynn N. Dulberger   +10 more
doaj   +1 more source

Erratum: The Role of Time as a Prognostic Factor in Pediatric Brain Tumors: a Multivariate Survival Analysis

open access: yesPathology and Oncology Research, 2022
Pathology and Oncology Research Production Office
doaj   +1 more source

Upgrading the SACT dataset and EBMT registry to enable outcomes-based reimbursement in oncology in England: a gap analysis and top-level cost estimate

open access: yesJournal of Market Access & Health Policy, 2019
Background: Outcomes-based reimbursement (OBR) can reduce decision uncertainty and accelerate patient access to cell and gene therapies, however, OBR is rarely applied in practice in England.
Jesper Jørgensen, Panos Kefalas
doaj   +1 more source

Erratum on: Chemotherapy in metastatic NSCLC – new regimens (pemetrexed, nab-paclitaxel)

open access: yesFrontiers in Oncology, 2014
Frontiers in Oncology Editorial Office
doaj   +1 more source

Home - About - Disclaimer - Privacy